Abstract
Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoring.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have